As healthcare spending continues to rise, payers and providers struggle to accurately measure value to patients, and with health systems all over the world shifting towards paying for value, not just volume, these efforts have never been more important.
Learn about PHE’s groundbreaking studies that have helped define the value of new oncology drugs, and why a variety of global stakeholders have turned to PHE to assist them in defining value in cancer care.
Download the free research brief, Innovations in Cancer Care: Capturing What Patients Value in the Calculus of Drug Costs, from Precision Health Economics.
It will make you rethink how value is being defined in the ongoing fight against cancer.